{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:16:54Z","timestamp":1788279414692,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA BC011708-09"],"award-info":[{"award-number":["ZIA BC011708-09"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ymeth.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:43:45Z","timestamp":1787438625000},"page":"48-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Resolving challenges in detection and quantification of D-2-hydroxyglutarate and L-2-hydroxyglutarate via LC\/MS"],"prefix":"10.1016","volume":"255","author":[{"given":"Tyrone","family":"Dowdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mioara","family":"Larion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2026.08.005_b0005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymeth.2026.08.005_b0010","doi-asserted-by":"crossref","unstructured":"Dang, L.; White, D.W.; Gross, S.; Bennett, B.D.; Bittinger, M.A.; Driggers, E.M.; Fantin, V.R.; Jang, H.G.; Jin, S.; Keenan, M.C., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate\u2014Nature 2009, 462, 739-744, doi:10.1038\/nature08617.","DOI":"10.1038\/nature08617"},{"key":"10.1016\/j.ymeth.2026.08.005_b0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20092506","article-title":"Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations","volume":"207","author":"Gross","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymeth.2026.08.005_b0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.ymeth.2026.08.005_b0025","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.humpath.2011.12.007","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma","volume":"43","author":"Kipp","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ymeth.2026.08.005_b0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nchembio.2307","article-title":"L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH","volume":"13","author":"Intlekofer","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymeth.2026.08.005_b0035","doi-asserted-by":"crossref","first-page":"20188","DOI":"10.1074\/jbc.M116.738799","article-title":"Acidic pH is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling","volume":"291","author":"Nadtochiy","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymeth.2026.08.005_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0009-8981(95)06074-N","article-title":"Identification of the D-enantiomer of 2-hydroxyglutaric acid in glutaric aciduria type II","volume":"238","author":"Watanabe","year":"1995","journal-title":"Clinica Chimica Acta; International Journal of Clinical Chemistry"},{"key":"10.1016\/j.ymeth.2026.08.005_b0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10545-012-9462-5","article-title":"Progress in understanding 2-hydroxyglutaric acidurias","volume":"35","author":"Kranendijk","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymeth.2026.08.005_b0050","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/01.WNL.0000125335.21381.87","article-title":"L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition?","volume":"62","author":"Moroni","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ymeth.2026.08.005_b0055","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/1078-0432.CCR-15-0656","article-title":"Treatment Response Assessment in IDH-Mutant Glioma patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate","volume":"22","author":"Andronesi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymeth.2026.08.005_b0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","article-title":"Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation","volume":"483","author":"Koivunen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2026.08.005_b0065","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1445454","article-title":"D-2-hydroxyglutarate interferes with HIF-1alpha stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization","volume":"7","author":"Bottcher","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymeth.2026.08.005_b0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.trecan.2017.12.005","article-title":"Metabolism, activity, and Targeting of D- and L-2-Hydroxyglutarates","volume":"4","author":"Ye","year":"2018","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.ymeth.2026.08.005_b0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature20165","article-title":"S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate","volume":"540","author":"Tyrakis","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2026.08.005_b0080","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.celrep.2015.11.029","article-title":"Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents","volume":"13","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymeth.2026.08.005_b0085","article-title":"Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes\u2014PLoS","volume":"15","author":"Tran","year":"2017","journal-title":"Biology"},{"key":"10.1016\/j.ymeth.2026.08.005_b0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N(6)-Methyladenosine RNA Demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymeth.2026.08.005_b0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ccell.2017.04.001","article-title":"IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation","volume":"31","author":"Elkashef","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymeth.2026.08.005_b0100","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1172\/JCI90644","article-title":"Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas","volume":"127","author":"Kohanbash","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymeth.2026.08.005_b0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG Exhibits Anti-tumor activity by Targeting FTO\/m(6)A\/MYC\/CEBPA Signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymeth.2026.08.005_b0110","doi-asserted-by":"crossref","first-page":"12700","DOI":"10.1038\/ncomms12700","article-title":"The oncometabolite 2-hydroxyglutarate activates the mTOR signaling pathway","volume":"7","author":"Carbonneau","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymeth.2026.08.005_b0115","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm.3788","article-title":"Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia","volume":"21","author":"Chan","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymeth.2026.08.005_b0120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bbrc.2012.06.002","article-title":"IDH1 and IDH2 have critical roles in 2-hydroxyglutarate production in D-2-hydroxyglutarate dehydrogenase depleted cells","volume":"423","author":"Matsunaga","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymeth.2026.08.005_b0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature20165","article-title":"S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate","volume":"540","author":"Tyrakis","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2026.08.005_b0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","article-title":"The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases","volume":"12","author":"Chowdhury","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymeth.2026.08.005_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00492-16","article-title":"L2hgdh deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration","volume":"37","author":"Ma","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymeth.2026.08.005_b0140","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1373\/clinchem.2004.033399","article-title":"Measurement of urinary D- and L-2-hydroxyglutarate enantiomers by stable-isotope-dilution liquid chromatography-tandem mass spectrometry after derivatization with diacetyl-L-tartaric anhydride","volume":"50","author":"Struys","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymeth.2026.08.005_b0145","doi-asserted-by":"crossref","unstructured":"Poinsignon, V.; Mercier, L.; Nakabayashi, K.; David, M.D.; Lalli, A.; Penard-Lacronique, V.; Quivoron, C.; Saada, V.; De Botton, S.; Broutin, S., et al. Quantitation of isocitrate dehydrogenase (IDH)-induced D and L enantiomers of 2-hydroxyglutaric acid in biological fluids by a fully validated liquid tandem mass spectrometry method, suitable for clinical applications. Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences 2016, 1022, 290-297, doi:10.1016\/j.jchromb.2016.04.030.","DOI":"10.1016\/j.jchromb.2016.04.030"},{"key":"10.1016\/j.ymeth.2026.08.005_b0150","doi-asserted-by":"crossref","first-page":"15217","DOI":"10.1038\/srep15217","article-title":"Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization combined with Liquid Chromatography\/Mass Spectrometry Analysis","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymeth.2026.08.005_b0155","doi-asserted-by":"crossref","first-page":"e1908","DOI":"10.21769\/BioProtoc.1908","article-title":"Quantification of 2-Hydroxyglutarate Enantiomers by Liquid Chromatography-Mass Spectrometry","volume":"6","author":"Oldham","year":"2016","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.ymeth.2026.08.005_b0160","first-page":"1","article-title":"Advantages of using Triple Quadrupole over Single Quadrupole Mass Spectrometry to Quantify and Identify the Presence of Pesticides in Water and Soil Samples","volume":"0701310\u201301","author":"Schreiber","year":"2010","journal-title":"AB Sciex"},{"key":"10.1016\/j.ymeth.2026.08.005_b0165","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/rcm.5178","volume":"25","author":"Xia","year":"2011","journal-title":"Rapid Communications in Mass Spectrometry: RCM"},{"key":"10.1016\/j.ymeth.2026.08.005_b0170","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymeth.2026.08.005_b0175","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1002\/cpbi.86","article-title":"Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis","volume":"68","author":"Chong","year":"2019","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ymeth.2026.08.005_b0180","unstructured":"The Theory of HPLC Chromatographic Parameters. Academy, C., Ed."},{"key":"10.1016\/j.ymeth.2026.08.005_b0185","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbadis.2011.08.006","article-title":"A lymphoblast model for IDH2 gain-of-function activity in d-2-hydroxyglutaric aciduria type II: Novel avenues for biochemical and therapeutic studies","volume":"1812","author":"Kranendijk","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ymeth.2026.08.005_b0190","first-page":"219","article-title":"Measurement of Oncometabolites D-2-Hydroxyglutaric Acid and L-2-Hydroxyglutaric Acid. Methods in molecular biology (Clifton","volume":"1633","author":"Jones","year":"2017","journal-title":"N.J.)"},{"key":"10.1016\/j.ymeth.2026.08.005_b0195","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1158\/1078-0432.CCR-15-2965","article-title":"Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma patients with Mutated Isocitrate Dehydrogenase","volume":"22","author":"Kalinina","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymeth.2026.08.005_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/bios9010005","article-title":"Detection of Metabolic changes Induced via Drug Treatments in Live Cancer Cells and Tissue using Raman Imaging Microscopy","volume":"9","author":"Larion","year":"2018","journal-title":"Biosensors"},{"key":"10.1016\/j.ymeth.2026.08.005_b0205","doi-asserted-by":"crossref","first-page":"39792","DOI":"10.1074\/jbc.M206955200","article-title":"Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3","volume":"277","author":"Huang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymeth.2026.08.005_b0210","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ccell.2015.11.006","article-title":"Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion","volume":"28","author":"Tateishi","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymeth.2026.08.005_b0215","doi-asserted-by":"crossref","unstructured":"Zhou, Z.; Ibekwe, E.; Chornenkyy, Y. Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change. Antioxidants (Basel, Switzerland) 2018, 7, doi:10.3390\/antiox7010016.","DOI":"10.3390\/antiox7010016"},{"key":"10.1016\/j.ymeth.2026.08.005_b0220","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the Intersections between Metabolism and Cancer Biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymeth.2026.08.005_b0225","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/febs.13295","article-title":"Oncometabolites: tailoring our genes","volume":"282","author":"Nowicki","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.ymeth.2026.08.005_b0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymeth.2026.08.005_b0235","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1007\/s13277-014-1784-5","article-title":"Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation","volume":"35","author":"Ohka","year":"2014","journal-title":"Tumor Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10.1016\/j.ymeth.2026.08.005_b0240","article-title":"Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut lower Grade Gliomas","author":"Victor","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ymeth.2026.08.005_b0245","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1101\/gad.217406.113","article-title":"What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer","volume":"27","author":"Losman","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymeth.2026.08.005_b0250","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnins.2015.00022","article-title":"Lactate is always the end product of glycolysis","volume":"9","author":"Rogatzki","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymeth.2026.08.005_b0255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2015.39.3.188","article-title":"Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers","volume":"39","author":"Jeoung","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.ymeth.2026.08.005_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046571","article-title":"Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells","volume":"7","author":"De Saedeleer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymeth.2026.08.005_b0265","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.1073\/pnas.1708914114","article-title":"Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1","volume":"114","author":"Mazor","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.ymeth.2026.08.005_b0270","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/neuonc\/not064","article-title":"Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line","volume":"15","author":"Luchman","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ymeth.2026.08.005_b0275","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/msb.2013.65","article-title":"Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia","volume":"9","author":"Fan","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ymeth.2026.08.005_b0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40170-015-0134-4","article-title":"Metabolic plasticity maintains proliferation in pyruvate dehydrogenase-deficient cells","volume":"3","author":"Rajagopalan","year":"2015","journal-title":"Cancer Metab."},{"key":"10.1016\/j.ymeth.2026.08.005_b0285","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/2159-8290.CD-13-0572","article-title":"A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor","volume":"4","author":"Elhammali","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymeth.2026.08.005_b0290","doi-asserted-by":"crossref","first-page":"31277","DOI":"10.1074\/jbc.M110.158485","article-title":"Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production","volume":"285","author":"Chua","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymeth.2026.08.005_b0295","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semradonc.2015.02.003","article-title":"Advances in magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma","volume":"25","author":"Kim","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.ymeth.2026.08.005_b0300","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002796","article-title":"Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas","volume":"4","author":"Elkhaled","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymeth.2026.08.005_b0305","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41467-018-03905-6","article-title":"Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate","volume":"9","author":"Andronesi","year":"2018","journal-title":"Nat. Commun."},{"issue":"30","key":"10.1016\/j.ymeth.2026.08.005_b0310","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.1073\/pnas.1404724111","article-title":"Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery","volume":"111","author":"Santagata","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymeth.2026.08.005_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2025.111062","article-title":"Luton H2-Hydroxyglutarate magnetic resonance spectroscopy for preoperative IDH molecular profiling \u2013 a review of the literature and real-world clinical translation in a busy neurosurgical neuro-oncology unit","volume":"133","author":"McHugh","year":"2025","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ymeth.2026.08.005_b0320","doi-asserted-by":"crossref","unstructured":"Nichelli L, Branzoli F, Valabregue R, Capelle L, Ottolenghi C, Bielle F, Lerond J, Giry M, Villa C, Galanaud D, Leh\u00e9ricy S, Marja\u0144ska M, Sanson M, Di Stefano A. PL1.2 Multiparametric assessment of factors influencing 2 HG accumulation in diffuse brain gliomas. Neuro Oncol. 2019 Sep;21(Suppl 3):iii1\u20132. doi: 10.1093\/neuonc\/noz126.001. Epub 2019 Sep 6. PMCID: PMC6787068.","DOI":"10.1093\/neuonc\/noz126.001"},{"issue":"17","key":"10.1016\/j.ymeth.2026.08.005_b0325","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3390\/diagnostics13172791","article-title":"The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma","volume":"13","author":"van Dijken","year":"2023","journal-title":"Diagnostics (Basel)"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:24:31Z","timestamp":1788276271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202326001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":65,"alternative-id":["S1046202326001830"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.08.005","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resolving challenges in detection and quantification of D-2-hydroxyglutarate and L-2-hydroxyglutarate via LC\/MS","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}